Azilsartan Impurity 52
|
阿齊沙坦雜質(zhì)52
|
139481-38-2
|
Edoxaban Impurity 88
|
依度沙班雜質(zhì)88
|
143150-92-9
|
Gamithromycin Impurity 2
|
加米霉素雜質(zhì)2
|
145414-17-1
|
Anagrelide impurity 35
|
阿那格雷雜質(zhì)35(正庚烷)
|
142-82-5
|
Nystatin
|
制霉菌素
|
1400-61-9
|
Neomycin sulfate
|
硫酸新霉素
|
1405-10-3
|
methylcobalamin
|
甲鈷胺
|
13422-55-4
|
1-(4-thiazolyl)-Cyclopropanol
|
1-(4-噻唑基)-環(huán)丙醇
|
1341931-43-8
|
4-methyl- [2- (2-2-2H-tetrazole-5-group)] biphenyl
|
4-甲基-[2-(2-三苯甲游基-2H-四唑-5-基)]聯(lián)苯
|
133909-97-4
|
Sodium hypobromate
|
次溴酸鈉
|
13824-96-9
|
Rifaximin EP Impurity E(Rifamycin EP Impurity B)
|
利福昔明EP雜質(zhì)E(利福霉素EP雜質(zhì)B)
|
13553-79-2
|
Tenofovir Impurity 82
|
替諾福韋雜質(zhì)82
|
1392275-56-7
|
Theophylline Impurity 10
|
茶堿雜質(zhì)10
|
1429636-73-6
|
Ticagrelor impurity 4
|
替格列汀雜質(zhì)4
|
1404559-22-3
|
Naringenin impurities1
|
柚皮素雜質(zhì)1
|
14259-46-2
|
Glycine impurity 7
|
甘氨酸雜質(zhì)7
|
13344-50-8
|
3-OXOISOINDOLIN-5-YLBORONIC ACID
|
3-氧代異吲哚啉-5-基硼酸
|
1370535-30-0
|
Donepezil Impurity 51
|
多奈哌齊雜質(zhì)51
|
138030-84-9
|
Indocyanine Green Impurity1
|
吲哚菁綠雜質(zhì)1
|
13959-24-5
|
Azacitidine Impurity 48
|
阿扎胞苷雜質(zhì)48
|
1415316-72-1
|
Gentamicin sulfate
|
硫酸慶大霉素
|
1405-41-0
|
Lobeline
|
洛貝林
|
90-69-7
|
Amiodarone Impurity 32
|
胺碘酮雜質(zhì)32
|
134-92-9
|
Ibandronate
|
伊班膦酸鈉
|
138844-81-2
|
Nicorandil Impurity 54
|
尼可地爾雜質(zhì)54
|
13589-33-8
|
Olmesartan Medoxomil Impurity 45
|
奧美沙坦酯雜質(zhì)45
|
1391052-99-5
|
Ebastine EP Impurity F
|
依巴斯汀EP雜質(zhì)F
|
1429071-63-5
|
Paliperidone Impurity 77
|
帕利哌酮雜質(zhì)77
|
1388021-47-3
|
Gimeracil impurity 2
|
吉美嘧啶雜質(zhì)2
|
1379260-15-7
|
Brimonidine Impurity 17
|
溴莫尼定雜質(zhì)17
|
134892-47-0
|
Raltegravir EP impurity C
|
雷特格韋EP雜質(zhì)C
|
1391918-17-4
|
Nalmefene impurity 10
|
納美芬雜質(zhì)10
|
144265-45-2
|
Tazobactam impurity 18
|
他唑巴坦雜質(zhì)18
|
1428131-22-9
|
Rifaximin EP Impurity B(Rifamycin EP Impurity A)
|
利福昔明EP雜質(zhì)B(利福霉素EP雜質(zhì)A)
|
13929-35-6
|
Landiolol Impurity 30
|
蘭地洛爾雜質(zhì)30
|
144256-25-7
|
Granulocyte colony stimulating factor
|
粒細(xì)胞集落刺激因子
|
143011-72-7
|
TEGRELLO impurity TAG-17 reference substance
|
替格瑞洛雜質(zhì)TAG-17對照品
|
|
Gadobutrol impurity 5
|
釓布醇雜質(zhì)5
|
137076-50-7
|
Ivacaftor impurities11
|
依伐卡托雜質(zhì)11
|
13721-01-2
|
Rivastigmine USP Related Compound F
|
卡巴拉汀(利斯的明)USP相關(guān)化合物F
|
1346602-84-3
|
Olmesartan Medoxomil Impurity 40
|
奧美沙坦酯雜質(zhì)40
|
144690-07-3
|
Dabigatran Impurity 27
|
達(dá)比加群雜質(zhì)27
|
1408238-36-7
|
Ibandronate sodium salt monhydrate
|
伊班膦酸鈉一水合物
|
138926-19-9
|
Apremilast Impurity 28
|
阿普斯特雜質(zhì)28
|
1384439-79-5
|
Sofosbuvir Impurity 30
|
索非布韋雜質(zhì)30
|
1392015-05-2
|
Pirentamivir impurity 5
|
哌侖他韋雜質(zhì)5
|
1332356-31-6
|
Moxifloxacin impurity 108
|
莫西沙星雜質(zhì)108
|
1403836-23-6
|
Vancomycin
|
萬古霉素
|
1404-90-6
|
Indocyanine green impurity 2
|
吲哚菁綠雜質(zhì)2
|
1351043-94-1
|
Pyridoxine Impurity 21
|
吡哆醇雜質(zhì)21
|
1385767-85-0
|
Formoterol Impurity 44
|
福莫特羅雜質(zhì)44
|
14347-05-8
|
Bromocriptine EP Impurity G
|
溴隱亭EP雜質(zhì)G
|
1349233-25-5
|
Brimonidine Impurity 16
|
溴莫尼定雜質(zhì)16
|
134892-46-9
|
Ketorolac Impurity 45
|
酮咯酸雜質(zhì)45
|
140947-23-5
|
Brimonidine Impurity 18
|
溴莫尼定雜質(zhì)18
|
135306-57-9
|
Olmesartan Medoxomil Impurity 44
|
奧美沙坦雜質(zhì)44
|
1443544-27-1
|
Zolpidem EP Impurity A
|
唑吡坦EP雜質(zhì)A
|
1346600-85-8
|
Eltrombopag Impurity 55
|
艾曲波帕雜質(zhì)55
|
1428987-67-0
|
N. N-Dimethyl-2-phenoxyethylamine
|
N,N-二甲基-2-苯氧基乙胺
|
13468-02-5
|
Ebastine EP Impurity G
|
依巴斯汀EP雜質(zhì)G
|
1429071-65-7
|
Enalapril EP impurity a
|
依那普利EP雜質(zhì)A
|
1356932-13-2
|
Indatrol Impurity 4
|
茚達(dá)特羅雜質(zhì)4
|
1403389-05-8
|
Ixaconazole - Intermediate 11(p-cyanoacetophenone)
|
艾沙康唑-中間體11(對氰基苯乙酮)
|
1443-80-7
|
Vonoprazan Impuirty103
|
沃諾拉贊雜質(zhì)103
|
134479-04-2
|
Troxerutin Impurity 7
|
曲克蘆丁雜質(zhì)7
|
13374-50-0
|
Mirogabalin Impurity 2
|
米洛巴林雜質(zhì)2
|
1415817-44-5
|
Balsalazide Related Compound 4
|
巴柳氮相關(guān)化合物4
|
1346606-62-9
|
Meloxicam Impurity 7
|
美洛昔康雜質(zhì)7
|
1391051-96-9
|
Sacubitril calcium salt(AHU-377 )
|
沙庫必曲鈣鹽(LCZ696中間體)
|
1369773-39-6
|
Gamithromycin Impurity 1
|
加米霉素雜質(zhì)1
|
145388-07-4
|
Trazodone BP Impurity E
|
曲唑酮BP雜質(zhì)E
|
1346599-35-6
|
Vincristine EP Impurity H(vinblastine) Sulfate
|
長春新堿EP雜質(zhì)H(長春堿)硫酸鹽
|
143-67-9
|
Pyridoxine Impurity 14
|
吡哆醇雜質(zhì)14
|
1385767-86-1
|
Terbinafine EP Impurity A
|
特比萘芬EP雜質(zhì)A
|
14489-75-9
|
3,4-dihydroxybenzaldehyde
|
3,4-二羥基苯甲醛
|
139-85-5
|
Fingolimod impurity 12
|
芬戈莫德雜質(zhì)12
|
1404233-80-2
|
Linezolid impurity 14
|
利奈唑胺雜質(zhì)14
|
1450876-94-4
|
Vancomycin Hydrochloride
|
鹽酸萬古霉素
|
1404-93-9
|
Iguratimod Impurity 28
|
艾拉莫德雜質(zhì)28
|
1340086-28-3
|
Olmesartan Medoxomil Impurity 39
|
奧美沙坦酯雜質(zhì)39
|
144689-63-4
|
Dextromethorphan EP Impurity D
|
右美沙芬EP雜質(zhì)D
|
1453167-99-1
|
Bromocyanamide metabolites
|
溴氰蟲酰胺代謝物
|
1414864-34-8
|
Minapram impurity 7
|
米那普侖雜質(zhì)7
|
1353644-49-1
|
Fluralaner-040
|
氟雷拉納-040
|
1437051-93-8
|
Pramipexole Impurity 52(DIHCl)
|
普拉克索雜質(zhì)52(二鹽酸鹽)
|
1432061-98-7
|
Ceftriaxone impurity 28
|
頭孢曲松雜質(zhì)28
|
139-33-3
|
Bromododecane
|
溴代十二烷
|
143-15-7
|
6.beta.-Naltrexol-d3
|
6-β-納曲醇D3(納曲酮雜質(zhì)6)
|
1435727-11-9
|
N - (3-chloroethyl) dibutylamine
|
N-(3-氯乙基)二丁基胺
|
13422-90-7
|
Atorvastatin Impurity 54
|
阿托伐他汀雜質(zhì)54
|
1050631-82-7
|
Ketorolac Impurity 44
|
酮咯酸雜質(zhì)44
|
136116-84-2
|
Domperidone EP impurity F (morphobutyline EP impurity F)
|
多潘立酮EP雜質(zhì)F(嗎丁啉EP雜質(zhì)F)
|
1391053-55-6
|
Donepezil Impurity 50
|
多奈哌齊雜質(zhì)50
|
14446-71-0
|
Methionine Impurity 3
|
蛋氨酸雜質(zhì)3
|
1433954-32-5
|
(1-Oxo-2,3-dihydro-1H-isoindol-5-yl)boronic acid
|
(1-氧代-2,3-二氫-1H-異吲哚-5-基)硼酸
|
1346526-56-4
|
Naphthyl ester EP impurity a
|
托萘酯EP雜質(zhì)A
|
135-19-3
|
Methyl 4-oxobutanoate
|
4-氧丁酸甲基酯
|
13865-19-5
|
Rifaximin EP Impurity F(Rifamycin EP Impurity C)
|
利福昔明EP雜質(zhì)F(利福霉素EP雜質(zhì)C)
|
14487-05-9
|
Topiroxostat Impurity 6
|
托匹司他雜質(zhì)6
|
13602-12-5
|
Ecrita impurity 1
|
依克立達(dá)雜質(zhì)1
|
143664-11-3
|